- Raised $10M funding round led by Pitango HealthTech, Jan 2020
- Raised $8.3M funding round, Feb 2017
- Raised $2.2M funding round, Jan 2015
About
CLEW uses artificial intelligence and data science to develop patient-level physiological predictive models. Originally developed and proven in the intensive care unit (ICU), the models are now being extended to all care settings, where they are used to assist healthcare providers in forecasting the state of their patients. Deployable from the patients bedside to a centralized command-and-control facility, CLEW is designed to help providers make better-informed clinical decisions, improve outcomes and safety, streamline patient care, better cope with increased regulation and penalties, lower the cost of care, and remove discharge barriers. CLEW is currently being deployed in ICUs across Israel and in the United States for telemedicine capabilities. In February 2021, the company received FDA clearance for its AI-based predictive analytics technology that supports patient assessment in adult intensive care units.
Funding history · 6 rounds · $20.5M total
Q&A
- What is CLEW's primary focus?
- CLEW specializes in developing patient-level physiological predictive models using artificial intelligence and data science, initially for intensive care units (ICU) and now expanding to all care settings.
- When did CLEW receive FDA clearance for its AI-based predictive analytics technology?
- In February 2021, CLEW received FDA clearance for its AI-based predictive analytics technology that supports patient assessment in adult intensive care units.
- Who are the co-founders of CLEW?
- The co-founders of CLEW are Gal Salomon, who serves as Co-founder & Executive Chairman, and Avigdor Faians, who is Co-founder & Chief Scientific and Regulatory Officer.
- Which investors participated in CLEW's January 2015 funding round?
- In January 2015, CLEW received funding from Rhon-Klinikum and Pitango HealthTech.
- Which investor led CLEW's January 2020 funding round?
- Pitango HealthTech led CLEW's funding round in January 2020.
- What is the total amount of funding CLEW has raised to date?
- CLEW has raised a total of $20,500,000 USD.
- What is CLEW's current funding stage?
- CLEW is currently in its Series C funding stage.
- Where is CLEW's headquarters located?
- CLEW's headquarters is located in Netanya, Israel.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | clewmed.com |
|---|---|
| linkedin.com/company/5393940 | |
| facebook.com/Intensix-1835587049784781 |
Identifiers & details
| Former names | Intensix |
|---|---|
| Founded | 2014-12 |
| Employees (exact) | 30 |
| Offices | Wilmington |
Radar intelligence
Patents
| EPO | 18 |
|---|
Publications (Crossref)
| Works | 10 |
|---|
Web history (Wayback)
| Domain | clewmed.com |
|---|
Certificate / subdomain footprint
| Subdomains | 57 |
|---|